Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fridrich

Showing results (281-290 of 286) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 286 results.
Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family ApproachEdwige Lorthiois, James Roache, David Barnes-Seeman, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
Cancer Discovery|November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from HyperinsulinemiaAndreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 29, 2012
Innovations in phenotyping of mouse models in the German Mouse ClinicHelmut Fuchs, Valérie Gailus-Durner, Susanne Neschen, et al.
JACC. Cardiovascular Interventions|January 5, 2024
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI StudyXavier Armario, Jennifer Carron, Andrew J Simpkin, et al.
Pageof 29

Showing results (281-290 of 286) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 286 results.
Journal of Medicinal Chemistry|June 20, 2020
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family ApproachEdwige Lorthiois, James Roache, David Barnes-Seeman, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
Cancer Discovery|November 2, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from HyperinsulinemiaAndreas Varkaris, Ermira Pazolli, Hakan Gunaydin, et al.
Journal of Medicinal Chemistry|September 10, 2020
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of CancerMatthew J LaMarche, Michael Acker, Andreea Argintaru, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 29, 2012
Innovations in phenotyping of mouse models in the German Mouse ClinicHelmut Fuchs, Valérie Gailus-Durner, Susanne Neschen, et al.
JACC. Cardiovascular Interventions|January 5, 2024
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI StudyXavier Armario, Jennifer Carron, Andrew J Simpkin, et al.
Pageof 29